Select area to zoom
Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '25100.0057.61

Key Stats

Customize
Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.93% -0.05% 580.66M 2.015M
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.24% 179.0% -245.55M Upgrade

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Equity
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

There are no valid items on this chart.

Name
2018
2019
2020
2021
2022
2023
2024
YTD
-57.60%
75.51%
74.66%
-64.15%
-80.36%
-13.42%
-26.02%
-35.66%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
4.25%
-39.89%
71.89%
-7.83%
27.87%
-62.48%
26.20%
7.21%
-23.27%
-39.21%
77.40%
-18.31%
72.89%
-49.27%
27.75%
20.33%
-17.79%
-56.75%
70.73%
-76.58%
108.3%
-54.10%
-55.81%
15.53%
-24.74%
-14.62%
63.45%
21.53%
60.57%
-38.98%
46.66%
43.47%
2.51%
As of June 26, 2025.

Asset Allocation

Created with Highcharts 11.1.0
As of May 31, 2025.
Type % Net
Cash 4.24%
Stock 73.82%
Bond 38.05%
Convertible 0.00%
Preferred 0.00%
Other -16.11%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Equity
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders

Quickflows